Article

Medicare now covers test for monitoring bladder cancer

Medicare groups in all but one state now cover the NMP22 BladderChek Test for both monitoring and diagnosis of bladder cancer, according to the test's manufacturer, Matritech.

Related Videos
2 experts in this video
2 experts in this video
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.